EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Moderate/Severe Biatrial Dilation Predicts Adverse Events After Ablation in Atrial Fibrillation with Heart Failure

Yan Yao iD, Bing Li, Jia Xue, Zhuo Chen, Xuemin Cai, Jiancheng Han, Xinyuan Zhou, Wenzhi Luo, Zhenhua Lu, Deyong Long, Zhihui Zhang

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14901 ↗

At a glance

Journal article in ESC Heart Failure, 2024. Written by Yan Yao and 10 co-authors. Institution: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Major MEDLINE topics: Atrial Fibrillation, Heart Failure, Catheter Ablation, Stroke Volume. 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Scientific Research Key Program of Beijing Municipal Commission of Education.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

To retrospectively compare the long-term outcomes following atrial fibrillation (AF) ablation between heart failure (HF) with preserved ejection fraction (EF) (HFpEF) and reduced/mildly reduced EF (HFr-mrEF) patients, and to identify novel predictors of adverse clinical events.

Methods

In total, 1402 AF patients with HF who underwent successful ablation were consecutively enrolled. Adverse clinical events including all-cause death, HF hospitalization, and stroke were followed up. Cox proportional hazards models were used to assess the associations between clinical factors and events. Kaplan–Meier analysis was performed to estimate the cumulative incidences of these events. A receiver operating characteristic curve was used to test the ability of these predictors.

Results

During a follow-up period of 42 ± 15 months, 265 (18.9%) patients experienced adverse clinical events after ablation. The cumulative incidence of adverse clinical events was significantly higher in HFr-mrEF than in HFpEF (25.4% vs. 15.7%, P < 0.001), the similar tendency was observed on all-cause death (10.5% vs. 6.5%, P = 0.011) and HF hospitalization (17.2% vs. 10.1%, P < 0.001). After multivariate adjustment, non-paroxysmal AF [hazard ratio (HR) 1.922, 95% confidence interval (CI) 1.130–3.268, P = 0.016], LAD ≥ 45 mm (HR 2.197, 95% CI 1.206–4.003, P < 0.001), LVEF (HR 0.959, 95% CI 0.946–0.981, P < 0.001), and RAD ≥ 45 mm (HR 2.044, 95% CI 1.362–3.238, P < 0.001) remained the independent predictors for developing adverse clinical events. A predictive model performed with non-paroxysmal AF, LAD ≥ 45 mm and RAD ≥ 45 mm yielded an area under curve of 0.728 (95% CI 0.696–0.760, P < 0.001).

Conclusions

AF patients with HFpEF had better long-term outcomes than those with HFr-mrEF, and moderate/severe biatrial dilation could predict adverse clinical events following catheter ablation in AF and HF patients.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationHeart FailureCatheter AblationStroke VolumeHeart AtriaHumansMaleFemaleRetrospective StudiesMiddle AgedFollow-Up StudiesAgedDilatation, PathologicIncidencePrognosisPostoperative ComplicationsSeverity of Illness Index

Author keywords

adverse clinical eventsatrial fibrillationcatheter ablationheart failurepredict

Authors and institutions

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Cardiology, Nanchong Central Hospital, Nanchong, China.
  • Echocardiography Medical Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Cardiology, the Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Cardiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID profiles: Yan Yao

Funding

  • National Natural Science Foundation of China
  • Scientific Research Key Program of Beijing Municipal Commission of Education

Cite

APA

Yao, Y., Li, B., Xue, J., Chen, Z., Cai, X., Han, J., Zhou, X., Luo, W., Lu, Z., Long, D., & Zhang, Z. (2024). Moderate/Severe Biatrial Dilation Predicts Adverse Events After Ablation in Atrial Fibrillation with Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.14901

Vancouver

Yao Y, Li B, Xue J, Chen Z, Cai X, Han J, et al. Moderate/Severe Biatrial Dilation Predicts Adverse Events After Ablation in Atrial Fibrillation with Heart Failure. ESC Heart Failure. 2024. doi:10.1002/ehf2.14901

BibTeX
@article{Yao2024,
  author = {Yao, Yan and Li, Bing and Xue, Jia and Chen, Zhuo and Cai, Xuemin and Han, Jiancheng and Zhou, Xinyuan and Luo, Wenzhi and Lu, Zhenhua and Long, Deyong and Zhang, Zhihui},
  title = {Moderate/Severe Biatrial Dilation Predicts Adverse Events After Ablation in Atrial Fibrillation with Heart Failure},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14901}
}
Start for free →